What is Pathology Services Laboratory?
Established in 1975, Pathology Services Laboratory operates as a critical diagnostic hub, providing comprehensive surgical pathology, cytopathology, and molecular infectious disease testing. The laboratory serves as a cornerstone for healthcare providers, utilizing board-certified expertise and advanced technological platforms to process thousands of specimens annually. Their operational model emphasizes high-precision diagnostic reporting, strict regulatory compliance, and personalized client engagement, which has allowed them to maintain a competitive edge in the regional medical services market for nearly five decades.
How much funding has Pathology Services Laboratory raised?
Pathology Services Laboratory has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pathology Services Laboratory
PPP
Public-Private Partnership
What's next for Pathology Services Laboratory?
With the infusion of this late-stage capital, Pathology Services Laboratory is well-positioned to modernize its molecular testing capabilities and expand its diagnostic reach. The strategic roadmap likely involves upgrading laboratory automation to improve turnaround times and integrating advanced digital pathology tools to support the growing demand for precision medicine. As the healthcare landscape shifts toward more complex molecular diagnostics, the firm's ability to scale its infrastructure while adhering to rigorous HIPAA standards will be pivotal in sustaining its growth trajectory and reinforcing its role as a primary diagnostic partner for regional healthcare systems.
See full Pathology Services Laboratory company page
